 Coronary artery disease CAD is a common disorder that can lead to heart failure. Not all people with CAD are eligible for todays standard treatments. One new treatment approach uses umbilical cord blood derived mesenchymal stem cellsspecialized cells capable of developing into other types of cellsto stimulate growth of new blood vessels for the heart. The aim of the present study is to investigate safety and efficacy of intramyocardial implantation of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy . 